Prometheon Pharma
About:
NoPricks: Needle-free insulin patches, new hair growth product, potential vaccine patches.
Website: http://prometheonpharma.com
Twitter/X: prometheonpharm
Description:
Platform biotech from University of Florida with needle-free transdermal patch delivery of large molecules. So far insulin, IGF-1, and hGH- 100x bigger than nicotine molecules delivered successfully to boost patient compliance and access. Initial $20B/year market with industry collaboration model that generates revenue before product launch.
Total Funding Amount:
$1.13M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Alachua, Florida, United States
Founded Date:
2011-01-01
Contact Email:
devon.grimme(AT)prometheonpharma.com
Founders:
Stephen Hsu
Number of Employees:
1-10
Last Funding Date:
2016-04-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai